These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7824895)

  • 1. Cell-cycle kinetics of proliferating mouse B lymphocytes in vitro.
    Källberg E; Leanderson T
    Scand J Immunol; 1995 Jan; 41(1):98-101. PubMed ID: 7824895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of B lymphocytes responsive to anti-immunoglobulin.
    Defranco AL; Raveche ES; Asofsky R; Paul WE
    J Exp Med; 1982 May; 155(5):1523-36. PubMed ID: 6802927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
    Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
    J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of bacterial lipopolysaccharide, anti-receptor antibodies and recombinant interferon on mouse B cell cycle progression using 5-bromo-2'-deoxyuridine/Hoechst 33258 dye flow cytometry.
    Seyschab H; Friedl R; Schindler D; Hoehn H; Rabinovitch PS; Chen U
    Eur J Immunol; 1989 Sep; 19(9):1605-12. PubMed ID: 2477251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive selection by "panning" of B lymphocytes using unfractionated anti-immunoglobulin antiserum.
    Rojo JM
    Rev Esp Fisiol; 1984 Dec; 40(4):463-7. PubMed ID: 6397795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of mouse lymphocytes by anti-immunoglobulin. II. A thymus-independent response by a mature subset of B lymphocytes.
    Sieckmann DG; Scher I; Asofsky R; Mosier DE; Paul WE
    J Exp Med; 1978 Dec; 148(6):1628-43. PubMed ID: 102729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cells from M167 mu kappa transgenic mice fail to proliferate after stimulation with soluble anti-Ig antibodies. A model for antigen-induced B cell anergy.
    Sieckmann DG; Holmes K; Hornbeck P; Martin E; Guelde G; Bondada S; Longo DL; Kenny JJ
    J Immunol; 1994 May; 152(10):4873-83. PubMed ID: 8176209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic convergence and divergence of surface immunoglobulin and CD40 signals.
    Axcrona K; Akerblad P; Leanderson T
    Scand J Immunol; 1998 Mar; 47(3):210-7. PubMed ID: 9519858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I.
    Kehrl JH; Muraguchi A; Fauci AS
    Eur J Immunol; 1984 Feb; 14(2):115-21. PubMed ID: 6199210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of anti-IgM suppression on polyclonally activated murine B cells: analysis of immunoglobulin mRNA, gene specific nuclear factors and cell cycle distribution.
    Marcuzzi A; Van Ness B; Rouse T; Lafrenz D
    Nucleic Acids Res; 1989 Dec; 17(24):10455-72. PubMed ID: 2481271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of resting B cells to DNA synthesis by soluble monoclonal anti-immunoglobulin.
    Julius MH; Heusser CH; Hartmann KU
    Eur J Immunol; 1984 Aug; 14(8):753-7. PubMed ID: 6332028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-lymphocyte signal transduction in response to anti-immunoglobulin and bacterial lipopolysaccharide.
    DeFranco AL; Gold MR; Jakway JP
    Immunol Rev; 1987 Feb; 95():161-76. PubMed ID: 3032773
    [No Abstract]   [Full Text] [Related]  

  • 13. Three restriction points in the cell cycle of activated murine B lymphocytes.
    Melchers F; Lernhardt W
    Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7681-5. PubMed ID: 3877931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune response against anti-idiotope antibodies II. The induction of antibodies bearing the target idiotope (Ab3 beta) depends on the frequency of the corresponding B cells.
    Tesch H; Takemori T; Rajewsky K
    Eur J Immunol; 1983 Sep; 13(9):726-32. PubMed ID: 6413225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of B cell growth and differentiation via CD21 and CD40.
    Axcrona K; Gray D; Leanderson T
    Eur J Immunol; 1996 Sep; 26(9):2203-7. PubMed ID: 8814268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a prominent nuclear protein associated with proliferation of normal and malignant B cells.
    Feuerstein N; Mond JJ
    J Immunol; 1987 Sep; 139(6):1818-22. PubMed ID: 2442256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse B cells do not proliferate in human interleukin 2.
    Leanderson T; Julius MH
    Eur J Immunol; 1986 Feb; 16(2):182-7. PubMed ID: 2869954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-4 enhances anti-IgM stimulation of B cells by improving cell viability and by increasing the sensitivity of B cells to the anti-IgM signal.
    Hodgkin PD; Go NF; Cupp JE; Howard M
    Cell Immunol; 1991 Apr; 134(1):14-30. PubMed ID: 2013100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Level of mIa expression on mitogen-stimulated murine B lymphocytes is dependent on position in cell cycle.
    Monroe JG; Cambier JC
    J Immunol; 1983 Feb; 130(2):626-31. PubMed ID: 6600247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgM RNA switch from membrane to secretory form is prevented by adding antireceptor antibody to bacterial lipopolysaccharide-stimulated murine primary B-cell cultures.
    Chen-Bettecken U; Wecker E; Schimpl A
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7384-8. PubMed ID: 3933005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.